.

Deeper Knowledge, Faster

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

UBS
Deloitte
Covington
Cantor Fitzgerald
Teva
Federal Trade Commission
Queensland Health
Cerilliant
Colorcon
McKesson

Generated: September 22, 2017

DrugPatentWatch Database Preview

Aralez Pharms Company Profile

« Back to Dashboard

What is the competitive landscape for ARALEZ PHARMS, and when can generic versions of ARALEZ PHARMS drugs launch?

ARALEZ PHARMS has four approved drugs.

There are ten US patents protecting ARALEZ PHARMS drugs on ARALEZ PHARMS drugs in the past three years.

There are one hundred and ninety-two patent family members on ARALEZ PHARMS drugs in thirty-nine countries.

Summary for Applicant: Aralez Pharms

Patents:10
Tradenames:4
Ingredients:4
NDAs:4
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Aralez Pharms
YOSPRALA
aspirin; omeprazole
TABLET, DELAYED RELEASE;ORAL205103-002Sep 14, 2016RXYesYes► Subscribe► Subscribe ► Subscribe
Aralez Pharms Inc
FIBRICOR
fenofibric acid
TABLET;ORAL022418-001Aug 14, 2009RXYesNo► Subscribe► Subscribe ► Subscribe
Aralez Pharms
ZONTIVITY
vorapaxar sulfate
TABLET;ORAL204886-001May 8, 2014RXYesYes► Subscribe► SubscribeYY ► Subscribe
Aralez Pharms
YOSPRALA
aspirin; omeprazole
TABLET, DELAYED RELEASE;ORAL205103-001Sep 14, 2016RXYesNo► Subscribe► Subscribe ► Subscribe
Aralez Pharms
TOPROL-XL
metoprolol succinate
TABLET, EXTENDED RELEASE;ORAL019962-003Jan 10, 1992ABRXYesYes► Subscribe► Subscribe► Subscribe
Aralez Pharms Inc
FIBRICOR
fenofibric acid
TABLET;ORAL022418-001Aug 14, 2009RXYesNo► Subscribe► Subscribe ► Subscribe
Aralez Pharms
YOSPRALA
aspirin; omeprazole
TABLET, DELAYED RELEASE;ORAL205103-002Sep 14, 2016RXYesYes► Subscribe► SubscribeY ► Subscribe
Aralez Pharms
TOPROL-XL
metoprolol succinate
TABLET, EXTENDED RELEASE;ORAL019962-004Feb 5, 2001ABRXYesNo► Subscribe► Subscribe► Subscribe
Aralez Pharms Inc
FIBRICOR
fenofibric acid
TABLET;ORAL022418-001Aug 14, 2009RXYesNo► Subscribe► Subscribe ► Subscribe
Aralez Pharms
YOSPRALA
aspirin; omeprazole
TABLET, DELAYED RELEASE;ORAL205103-001Sep 14, 2016RXYesNo► Subscribe► SubscribeY ► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Aralez Pharms

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Aralez Pharms
TOPROL-XL
metoprolol succinate
TABLET, EXTENDED RELEASE;ORAL019962-001Jan 10, 1992► Subscribe► Subscribe
Aralez Pharms
TOPROL-XL
metoprolol succinate
TABLET, EXTENDED RELEASE;ORAL019962-002Jan 10, 1992► Subscribe► Subscribe
Aralez Pharms
TOPROL-XL
metoprolol succinate
TABLET, EXTENDED RELEASE;ORAL019962-001Jan 10, 1992► Subscribe► Subscribe
Aralez Pharms
TOPROL-XL
metoprolol succinate
TABLET, EXTENDED RELEASE;ORAL019962-002Jan 10, 1992► Subscribe► Subscribe
Aralez Pharms
TOPROL-XL
metoprolol succinate
TABLET, EXTENDED RELEASE;ORAL019962-004Feb 5, 2001► Subscribe► Subscribe
Aralez Pharms
TOPROL-XL
metoprolol succinate
TABLET, EXTENDED RELEASE;ORAL019962-004Feb 5, 2001► Subscribe► Subscribe
Aralez Pharms
TOPROL-XL
metoprolol succinate
TABLET, EXTENDED RELEASE;ORAL019962-003Jan 10, 1992► Subscribe► Subscribe
Aralez Pharms
TOPROL-XL
metoprolol succinate
TABLET, EXTENDED RELEASE;ORAL019962-002Jan 10, 1992► Subscribe► Subscribe
Aralez Pharms
TOPROL-XL
metoprolol succinate
TABLET, EXTENDED RELEASE;ORAL019962-003Jan 10, 1992► Subscribe► Subscribe
Aralez Pharms
TOPROL-XL
metoprolol succinate
TABLET, EXTENDED RELEASE;ORAL019962-004Feb 5, 2001► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Paragraph IV activity for ARALEZ PHARMS drugs

Drugname Dosage Strength Tradename Submissiondate
aspirin and omeprazole
Delayed-release Tablets 81 mg/40 mg
YOSPRALA
10/14/2016

Non-Orange Book Patents for Aralez Pharms

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
6,645,987 Nor-seco himbacine derivatives useful as thrombin receptor antagonists► Subscribe
6,894,065 Thrombin receptor antagonists► Subscribe
8,557,285Pharmaceutical compositions for the coordinated delivery of NSAIDs► Subscribe
9,161,920Pharmaceutical compositions for the coordinated delivery of NSAIDs► Subscribe
8,865,190Pharmaceutical compositions for the coordinated delivery of NSAIDs► Subscribe
7,488,742Thrombin receptor antagonists► Subscribe
8,858,996Pharmaceutical compositions for the coordinated delivery of NSAIDS► Subscribe
9,707,181Pharmaceutical compositions for the coordinated delivery of NSAIDs► Subscribe
9,345,695Pharmaceutical compositions for the coordinated delivery of NSAIDs► Subscribe
9,393,208Method for delivering a pharmaceutical composition to patient in need thereof► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Because of the complexity of determining patent expiration dates it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Aralez Pharms Drugs

Country Document Number Estimated Expiration
South Africa201102645► Subscribe
European Patent Office2163241► Subscribe
Australia2009200966► Subscribe
Hungary0303081► Subscribe
Spain2338171► Subscribe
Russian Federation2355689► Subscribe
TaiwanI343919► Subscribe
Taiwan200526643► Subscribe
Slovakia17552002► Subscribe
World Intellectual Property Organization (WIPO)02098352► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

Supplementary Protection Certificates for Aralez Pharms Drugs

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
2012 00036Denmark► Subscribe
2015027,C1495018Lithuania► SubscribePRODUCT NAME: VORAPAKSARAS; REGISTRATION NO/DATE: EU/1/14/976/001 - EU/1/14/976/006 20150119
90037-6Sweden► SubscribePRODUCT NAME: VORAPAXAR, OR A PHARMACEUTICALLY ACCEPTABLE SALT OR SOLVATE THEREOF; REG. NO/DATE: EU/1/14/976/001 20150121
00746Netherlands► SubscribePRODUCT NAME: VORAPAXAR IN ELKE DOOR HET; REGISTRATION NO/DATE: EU/1/14/976/001-006 20150119
8 50011-2015Slovakia► SubscribePRODUCT NAME: VORAPAXARIUMSULFAT; REGISTRATION NO/DATE: EU/1/14/976/001 - EU/1/14/976/006 20150121
2015000053Germany► SubscribePRODUCT NAME: VORAPAXAR ODER EIN PHARMAZEUTISCH ANNEHMBARES SALZ ODER SOLVAT DAVON; REGISTRATION NO/DATE: EU/1/14/976/001-006 20150119
11/016Ireland► SubscribePRODUCT NAME: NAPROXEN AND ESOMEPRAZOLE MODIFIED-RELEASE TABLETS; NAT REGISTRATION NO/DATE: PA0970/060/001 20101221; FIRST REGISTRATION NO/DATE: PL17901/0263-0001 20101105
0150025 00159Estonia► SubscribePRODUCT NAME: VORAPAKSAAR;REG NO/DATE: EU/1/14/976 21.01.2015
15/035Ireland► SubscribePRODUCT NAME: VORAPAXAR, OR A PHARMACEUTICALLY ACCEPTABLE SALT OR SOLVATE THEREOF; REGISTRATION NO/DATE: EU/1/14/976/001-006 20150119
00481Netherlands► SubscribePRODUCT NAME: NAPROXEN EN ESOMEPRAZOL; NAT. REGISTRATION NO/DATE: RVG 106235 20101118; FIRST REGISTRATION: PL 17901/0263-001 20101105
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Covington
Farmers Insurance
QuintilesIMS
Teva
Fish and Richardson
Julphar
Citi
Cerilliant
Cipla
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot